Trials / Completed
CompletedNCT06690502
Post Authorization Safety Profile of Booster IndoVac COVID-19 Vaccination
Safety Profile of Booster IndoVac COVID-19 Vaccination in Healthy Populations Aged 18 Years and Above
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,208 (actual)
- Sponsor
- PT Bio Farma · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study is Post Authorization Safety Study (PASS) Phase IV of Booster IndoVac COVID-19 Vaccination
Detailed description
This study is Post Authorization Safety Study (PASS) Phase IV, to assess any local and systemic reaction after immunization with IndoVac using retrospective cohort study trial design to assess safety profile following IndoVac booster vaccine in healthy populations aged 18 years and above.
Conditions
Timeline
- Start date
- 2023-12-18
- Primary completion
- 2024-06-03
- Completion
- 2024-06-07
- First posted
- 2024-11-15
- Last updated
- 2024-11-15
Locations
28 sites across 1 country: Indonesia
Source: ClinicalTrials.gov record NCT06690502. Inclusion in this directory is not an endorsement.